title: Additional experiences with corticosteroids in COPD.
authors.forename: F W
authors.initials: FW
authors.lastname: Smeenk
authors.forename: P J
authors.initials: PJ
authors.lastname: Klinkhamer
authors.forename: W
authors.initials: W
authors.lastname: Breed
authors.forename: A R
authors.initials: AR
authors.lastname: Jansz
authors.forename: C A
authors.initials: CA
authors.lastname: Jansveld
mesh_terms: D000368:Aged; D001228:Aspergillosis / Q000139:chemically induced; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000139:chemically induced; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000139:chemically induced; D009894:Opportunistic Infections / Q000139:chemically induced
chemical_list: D005938:Glucocorticoids; D019819:Budesonide